Prestige Biologics Co Ltd banner
P

Prestige Biologics Co Ltd
KOSDAQ:334970

Watchlist Manager
Prestige Biologics Co Ltd
KOSDAQ:334970
Watchlist
Price: 2 760 KRW -1.25% Market Closed
Market Cap: ₩214.6B

Dividends

Prestige Biologics Co Ltd
does not pay dividends

Shareholder Yield

Current shareholder yield for Prestige Biologics Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield
Prestige Biologics Co Ltd

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
Prestige Biologics Co Ltd

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

Price
Prestige Biologics Co Ltd

Annual Price Range
2 760
52w Low
2 760
52w High
4 840
Price Metrics
Average Annual Return -9.27%
Standard Deviation of Annual Returns 54.57%
Max Drawdown -86%
Shares Statistics
Market Capitalization 214.6B KRW
Shares Outstanding 77 750 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

Stock Splits

No Stock Splits Found

We don't have any information about Prestige Biologics Co Ltd's stock splits.

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett